Nicosia: President of the Cyprus Space Exploration Organisation (CSEO), George Danos, has highlighted Cyprus' involvement in NASA's Artemis mission, underscoring the nation's contributions to addressing astronaut health issues via collaborative research with the Cyprus Institute of Neurology and Genetics.
According to Cyprus News Agency, Danos emphasized the significance of the Artemis mission as a historic moment for humanity, marking a return to lunar exploration after over half a century. While the current mission is not a lunar landing but a journey around the Moon, preparations are underway for the Artemis 4 mission, which aims to establish lunar bases. This mission signifies not just a visit but a long-term commitment to research and technological development on the Moon.
In October 2024, Cyprus joined the United States in signing the Artemis Accords. CSEO has established multiple agreements with key entities like Lockheed Martin and NASA, focusing on studying astronaut health. Danos highlighted the importance of protecting astronauts in future moon bases from challenges such as solar radiation and microgravity.
The research, conducted in collaboration with NASA, has identified specific health problems faced by astronauts, and proposed pharmaceutical treatments have been developed. This work, involving the Cyprus Institute of Neurology and Genetics, has positioned Cyprus as a significant player in the international space community.
Danos expressed optimism that the collaborative efforts in Cyprus will yield results beneficial to the Artemis mission, the broader Artemis program, and Cyprus itself. He also pointed out the mission's potential to discover lunar resources that could address Earth's resource needs, particularly for renewable energy and essential materials like lithium.
Finally, Danos noted the burgeoning economic potential of the space sector, predicting revenues reaching one trillion dollars by the decade's end.